X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PFIZER DR. DATSONS LABS/
PFIZER
 
P/E (TTM) x -10.9 31.2 - View Chart
P/BV x 0.2 5.0 3.3% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   PFIZER
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PFIZER
Mar-16
DR. DATSONS LABS/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1262,724 4.6%   
Low Rs311,611 1.9%   
Sales per share (Unadj.) Rs133.0440.9 30.2%  
Earnings per share (Unadj.) Rs0.248.7 0.3%  
Cash flow per share (Unadj.) Rs6.675.8 8.7%  
Dividends per share (Unadj.) Rs015.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs128.8462.9 27.8%  
Shares outstanding (eoy) m31.6645.75 69.2%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.9 12.0%   
Avg P/E ratio x516.144.5 1,159.5%  
P/CF ratio (eoy) x11.828.6 41.4%  
Price / Book Value ratio x0.64.7 13.0%  
Dividend payout %030.8 0.0%   
Avg Mkt Cap Rs m2,47799,163 2.5%   
No. of employees `000NA2.9 0.0%   
Total wages/salary Rs m562,758 2.0%   
Avg. sales/employee Rs ThNM6,981.7-  
Avg. wages/employee Rs ThNM954.5-  
Avg. net profit/employee Rs ThNM771.1-  
INCOME DATA
Net Sales Rs m4,21120,170 20.9%  
Other income Rs m79857 9.2%   
Total revenues Rs m4,28921,028 20.4%   
Gross profit Rs m5694,310 13.2%  
Depreciation Rs m2041,239 16.5%   
Interest Rs m4305 8,273.1%   
Profit before tax Rs m133,923 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m61,794 0.3%   
Profit after tax Rs m52,228 0.2%  
Gross profit margin %13.521.4 63.2%  
Effective tax rate %48.045.7 105.0%   
Net profit margin %0.111.0 1.0%  
BALANCE SHEET DATA
Current assets Rs m6,85216,299 42.0%   
Current liabilities Rs m6,7117,594 88.4%   
Net working cap to sales %3.343.2 7.8%  
Current ratio x1.02.1 47.6%  
Inventory Days Days16165 246.4%  
Debtors Days Days31826 1,236.8%  
Net fixed assets Rs m3,6738,622 42.6%   
Share capital Rs m317458 69.2%   
"Free" reserves Rs m3,76120,722 18.1%   
Net worth Rs m4,07821,180 19.3%   
Long term debt Rs m1,67125 6,683.2%   
Total assets Rs m12,63329,137 43.4%  
Interest coverage x1.0755.5 0.1%   
Debt to equity ratio x0.40 34,714.8%  
Sales to assets ratio x0.30.7 48.1%   
Return on assets %3.47.7 44.9%  
Return on equity %0.110.5 1.1%  
Return on capital %7.719.0 40.4%  
Exports to sales %22.90.1 38,483.2%   
Imports to sales %14.317.5 81.8%   
Exports (fob) Rs m96412 8,033.3%   
Imports (cif) Rs m6023,526 17.1%   
Fx inflow Rs m96452 1,866.4%   
Fx outflow Rs m607140 433.7%   
Net fx Rs m357-88 -404.1%   
CASH FLOW
From Operations Rs m1,3453,436 39.1%  
From Investments Rs m-2,256-6,991 32.3%  
From Financial Activity Rs m-1,200-619 193.9%  
Net Cashflow Rs m-2,111-4,174 50.6%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 1.4 4.9 27.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 23.7 397.0%  
Shareholders   20,807 85,207 24.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   JUBILANT LIFE SCIENCES  PLETHICO PHARMA  WOCKHARDT LTD.  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS